Glucagon-like peptide-1 Regulate Receptor of Advanced Glycation End Products in High Glucose Treated Rat Mesangial Cells
碩士 === 國立陽明大學 === 藥理學研究所 === 101 === Diabetic nephropathy is the leading cause of end stage renal disease which needs regular dialysis therapy. Advanced glycation end products (AGE) and receptors of AGE (RAGE) play important pathological roles in progression of diabetic nephropathy. Both glucagon-li...
Main Authors: | Jui-Ting Chang, 張瑞廷 |
---|---|
Other Authors: | Jyh-Gang Leu |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/60729801982222448021 |
Similar Items
-
Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
by: Jui-Ting Chang, et al.
Published: (2017-10-01) -
Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells
by: Tsuji, Hiroko
Published: (2014) -
An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
by: Alessandra Puddu, et al.
Published: (2013-01-01) -
Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
by: Takaaki Murakami, et al.
Published: (2020-11-01) -
Protective Effects of Kaempferitrin on Advanced Glycation End Products Induce Mesangial Cell Apoptosis and Oxidative Stress
by: Wenxian Jiang, et al.
Published: (2018-10-01)